|
|
||||||||
Articles |
Infants with upper gut atresia often have impaired intrauterine growth and gut function. IGF-I is important in fetal growth and is contained in amniotic fluid. We therefore wanted to test the hypothesis that IGF-I infused into fetal gut would reverse the effects of an upper gut obstruction on gut structure and growth in fetal sheep. At 90 days gestation fetuses (n=6 per group) underwent oesophageal ligation, followed by continuous infusion of IGF-I (1-8 microgram/day) or saline into the gut beyond the ligation until 137 days. Controls underwent sham ligation only. Oesophageal ligation tended to reduce fetal body and organ weights. IGF-I treatment prevented this reduction and increased body length and spleen weight above those of controls. The decrease in bowel wall thickness induced by oesophageal ligation was also prevented by IGF-I treatment. Amniotic fluid IGF-I concentrations did not change over gestation and were higher in the IGF-I treated group. No change in fetal plasma IGF-I concentrations were detectable. We conclude that enterally administered IGF-I may enhance fetal growth and gut development in utero and that IGF-I in amniotic fluid may play a physiological role in gut development in the fetus.
This article has been cited by other articles:
![]() |
S. C. Eremia, H. A. de Boo, F. H. Bloomfield, M. H. Oliver, and J. E. Harding Fetal and Amniotic Insulin-Like Growth Factor-I Supplements Improve Growth Rate in Intrauterine Growth Restriction Fetal Sheep Endocrinology, June 1, 2007; 148(6): 2963 - 2972. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Underwood and M. P. Sherman Nutritional Characteristics of Amniotic Fluid NeoReviews, June 1, 2006; 7(6): e310 - e316. [Full Text] [PDF] |
||||
![]() |
A. Hellstrom, E. Engstrom, A.-L. Hard, K. Albertsson-Wikland, B. Carlsson, A. Niklasson, C. Lofqvist, E. Svensson, S. Holm, U. Ewald, et al. Postnatal Serum Insulin-Like Growth Factor I Deficiency Is Associated With Retinopathy of Prematurity and Other Complications of Premature Birth Pediatrics, November 1, 2003; 112(5): 1016 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Bloomfield, M. K. Bauer, P. L. Van Zijl, P. D. Gluckman, and J. E. Harding Amniotic IGF-I supplements improve gut growth but reduce circulating IGF-I in growth-restricted fetal sheep Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E259 - E269. [Abstract] [Full Text] [PDF] |
||||
![]() |
S E Juul, D J Ledbetter, A E Joyce, C Dame, R D Christensen, Y Zhao, and V DeMarco Erythropoietin acts as a trophic factor in neonatal rat intestine Gut, August 1, 2001; 49(2): 182 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hellstrom, C. Perruzzi, M. Ju, E. Engstrom, A.-L. Hard, J.-L. Liu, K. Albertsson-Wikland, B. Carlsson, A. Niklasson, L. Sjodell, et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity PNAS, May 8, 2001; 98(10): 5804 - 5808. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |